SCHEMBL3670255

SCHEMBL3670255

Cc1cc(C)c(CCCC(=O)O)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GPR17 Q13304 1/20 0.47
TSHR P16473 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPK1 P28482 2/20 0.45
HDAC3 O15379 1/20 0.45
ADRA1A P35348 1/20 0.45
HDAC4 P56524 1/20 0.45
SLC6A3 Q01959 1/20 0.45
HDAC1 Q13547 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14988768 0.89 NPSR1 (0.57) FABP4NPSR1GPR17TSHRMEN1
SCHEMBL9336629 0.89 FABP4 (0.45) FABP4NPSR1GPR17TSHRMAPK1
SCHEMBL22190396 0.83 MAPK1 (0.55) FABP4NPSR1TSHRMAPK1HDAC3
SCHEMBL29009941 0.80 FFAR1 (0.46) FABP4NPSR1TSHRMEN1KMT2A
SCHEMBL1454248 0.79 TSHR (0.56) NPSR1TSHRMEN1KMT2AMAPK1
SCHEMBL11392001 0.78 GPR17 (0.42) NPSR1GPR17MEN1KMT2AHDAC3
SCHEMBL28045328 0.78 MAPT (0.55) FABP4MAPK1HDAC3ADRA1AHDAC4
SCHEMBL11099663 0.77 KDM4E (0.44) NPSR1GPR17TSHRSLC6A3SMN1; SMN2
SCHEMBL6017716 0.77 GPR17 (0.41) NPSR1GPR17MEN1KMT2AKDM4E
SCHEMBL9861837 0.76 HDAC3 (0.52) NPSR1TSHRMAPK1HDAC3ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1511707-B1 PROCESS FOR PRODUCING AROMATIC COMPOUNDS BY FRIEDEL-CRAFTS REACTION SHOWA DENKO KK (JP) 2010-05-19 EP disclosed
US-20090131384-A1 COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH ER STRESS SYNDEXA PHARMACEUTICALS CORPORATION (US) 2009-05-21 US disclosed
US-20090131384-A1 COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH ER STRESS SYNDEXA PHARMACEUTICALS CORPORATION (US) 2009-05-21 US disclosed
WO-2007111994-A2 COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH ER STRESS SYNDEXA PHARMACEUTICALS CORPORATION (US) 2007-10-04 WO disclosed
US-7115782-B2 Process for producing aromatic compounds by Friedel-Crafts reaction SHOWA DENKO K.K. (JP) 2006-10-03 US disclosed
US-20050222457-A1 Process for producing aromatic compounds by friedel-crafts reaction SHOWA DENKO K.K. (JP) 2005-10-06 US disclosed
EP-1511707-A1 PROCESS FOR PRODUCING AROMATIC COMPOUNDS BY FRIEDEL-CRAFTS REACTION Showa Denko K.K. (JP) 2005-03-09 EP disclosed
WO-2003101925-A1 PROCESS FOR PRODUCING AROMATIC COMPOUNDS BY FRIEDEL-CRAFTS REACTION SHOWA DENKO K. K. (JP) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222457-A1 Process for producing aromatic compounds by friedel-crafts reaction PAH, DDC, TYR FABP4 274/4885NPSR1 2321/4885GPR17 2356/4885
US-20090131384-A1 COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH ER STRESS NR1H3, NR1H2, SREBF1 FABP4 488/4885NPSR1 2102/4885GPR17 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.